Adenocarcinoma of the liver and intrahepatic biliary tract

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

2 events
Oct 2022PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING
Dec 2021Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

National Cancer Institute (NCI) — PHASE2

TrialACTIVE NOT RECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Adenocarcinoma of the liver and intrahepatic biliary tract.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
2Phase 2
2Total recruiting
Search clinical trials for Adenocarcinoma of the liver and intrahepatic biliary tract

Recent News & Research

No recent news articles indexed yet for Adenocarcinoma of the liver and intrahepatic biliary tract.
Search PubMed for Adenocarcinoma of the liver and intrahepatic biliary tract

Browse all Adenocarcinoma of the liver and intrahepatic biliary tract news →

Specialist Network

Top 4 by expertise

View all Adenocarcinoma of the liver and intrahepatic biliary tract specialists →

Quick Actions